Kyoto, Japan

Hiroshi Ichise

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Kyoto University, Thyas Co. Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Ichise. Retrieved from https://idiyas.com/inventor/hiroshi-ichise-4q0cpeij

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Ichise: Innovator in Cell-Based Immunotherapy

Introduction

Hiroshi Ichise is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of immunotherapy, particularly through his innovative methods for inducing T cells from pluripotent stem cells. His work is crucial in advancing cell-based therapies for various diseases.

Latest Patents

Hiroshi Ichise holds a patent titled "Method for inducing T cells for cell-based immunotherapy from pluripotent stem cells." This patent outlines a method that includes specific steps for inducing T cells, which are essential for effective immunotherapy treatments. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Throughout his career, Hiroshi Ichise has worked with esteemed institutions, including Kyoto University and Thyas Co. Ltd. His experience in these organizations has allowed him to develop and refine his innovative approaches to immunotherapy.

Collaborations

Hiroshi Ichise has collaborated with notable colleagues such as Atsutaka Minagawa and Shin Kaneko. These partnerships have contributed to the advancement of research and development in the field of cell-based therapies.

Conclusion

Hiroshi Ichise's work in the field of immunotherapy exemplifies the impact of innovative thinking in medicine. His contributions continue to pave the way for new treatments and therapies that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…